Public Defence: Sophie Emilie Bresson

M.Sc. Sophie Emilie Bresson at Institute of Basic Medical Sciences will be defending the thesis “Mechanistic insights into the impact of persistent organic pollutants on pancreatic beta-cell function and the role of Nr1i2 in intestinal homeostasis” for the degree of PhD (Philosophiae Doctor).

Bildet kan inneholde: klær, hår, hake, smil, kinn.

Photo: UiO.

Click here to stream the public defence

Due to copyright issues, an electronic copy of the thesis must be ordered from the faculty. For the faculty to have time to process the order, the order must be received by the faculty at the latest 2 days before the public defence. Orders received later than 2 days before the defence will not be processed. After the public defence, please address any inquiries regarding the thesis to the candidate.

Trial Lecture – time and place

See Trial Lecture.

Adjudication committee

  • First opponent: Professor Juliette Legler, Utrecht University,
  • Second opponent: Professor Harald Carlsen, Norwegian University of Life Sciences,
  • Third member and chair of the evaluation committee: Professor Rune Blomhoff, University of Oslo

Chair of the Defence

Associate Professor Frode Norheim, University of Oslo

Principal Supervisor

Professor Jerome Ruzzin, University of Oslo

Summary

Persistent organic pollutants (POPs) are widespread in the environment despite concerns about their potential impact on human health. The UN and WHO note a lack of data on how POPs may cause diabetes, and the functions of POP receptors like NR1I2 are not well understood.

The first part of this thesis examines how POPs affect pancreatic β-cells and contribute to diabetes. We found that youths with type 1 diabetes had high levels of POPs like PCB-153 and p,p’-DDE. In cultured pancreatic β-cells, POPs reduced insulin production by impairing the antioxidant defense of the cells. Moreover, long-term exposure to POPs led to β-cell death. The second part of the thesis explores the role of intestinal NR1I2. Mice lacking NR1I2 in the gut showed no significant changes in intestinal structure or function compared to control mice, even when challenged with lipopolysaccharide (LPS).

Additional information

Contact the research support staff.

Published Mar. 14, 2025 12:27 PM - Last modified Mar. 26, 2025 3:31 PM